Introduction

Migraines are complex neurological disorders characterised by recurrent, often severe headaches. They are typically unilateral and pulsating in nature, lasting between 4 and 72 hours. They are frequently accompanied by additional symptoms such as nausea, vomiting, photophobia (sensitivity to light) and phonophobia (sensitivity to loud sounds). Migraine attacks often proceed through phases, including prodrome, aura (in 20–30% of patients), headache, and postdrome. The exact cause remains unclear, but migraines are understood to involve hyperexcitability of some brain regions, like cortical and subcortical structures, particularly in the trigeminovascular system (which innervates the cerebral vasculature). Genetic predisposition and environmental triggers such as stress, dietary factors, and hormonal fluctuations also contribute to their occurrence.^1,2

Hyperhidrosis is a condition marked by excessive sweating beyond what is physiologically necessary for the body to maintain a steady internal body temperature. It can be classified as primary (idiopathic) or secondary (linked to underlying conditions such as hormonal imbalances, neurological disorders, or medication use). The condition primarily affects the palms, soles, axillae, and face, but can occur anywhere on the body. Secondary hyperhidrosis is often a result of systemic diseases like hyperthyroidism, diabetes, or neurologic syndromes that dysregulate the autonomic nervous system (ANS), the same system implicated in migraine.³

This article will explore the potential relationship between migraines and excessive sweating. Given the shared involvement of the autonomic nervous system in both conditions, understanding this link could have implications for better diagnosis, management, and treatment of affected individuals. Furthermore, recognising sweating as a possible symptom of migraines may help in distinguishing migraine episodes from other conditions. 

Background on migraines 

Triggers and causes

Migraines are believed to arise from a combination of genetic, environmental, and neurological factors. Up to 60% of migraine sufferers report a family history of the condition, underscoring a strong genetic predisposition. Variants in genes affecting ion channels, such as CACNA1A and SCN1A, have been implicated, especially in specific subtypes like familial hemiplegic migraine.⁴

Environmental factors frequently act as triggers for migraines. These can include stress, hormonal fluctuations (e.g., menstruation) and dietary components such as caffeine, alcohol, and specific food additives (e.g., monosodium glutamate). In particular, sleep disturbances, both deprivation and excess, disrupt homeostatic brain activity and can lower the threshold for triggering migraine episodes.⁵ Weather changes, bright lights, and strong odours are commonly reported triggers.

Phases of a migraine

Migraine typically occur in distinct phases, each presenting with unique features:⁶

Prodrome

The prodrome phase occurs hours to days before the headache and includes nonspecific symptoms such as irritability, fatigue, neck stiffness, increased yawning, and food cravings. This phase reflects altered hypothalamic activity in the brain and precedes the full-blown migraine attack in approximately 60% of cases.

Aura

Auras are transient neurological symptoms experienced by about 20-30% of migraine sufferers. They often include visual disturbances such as flashing lights, zigzag patterns, or temporary vision loss. Sensory (e.g., numbness or tingling), motor, and language disturbances can also occur. The pathophysiology of aura involves cortical spreading depression – a wave of neuronal depolarisation followed by inhibition – that propagates across the brain's cortex.

Headache phase

The headache phase is characterised by unilateral, pulsating pain that typically lasts 4 to 72 hours. It is often accompanied by nausea, vomiting, and heightened sensitivity to light, sound, and odours. The activation of the trigeminovascular system plays a critical role, with the release of neuropeptides like calcitonin gene-related peptide (CGRP) causing vasodilation and inflammation in cranial blood vessels.

Postdrome

Following the resolution of the headache, patients often experience postdrome symptoms such as fatigue, cognitive fog, and residual neck pain. This phase, lasting up to 24 hours, reflects lingering central nervous system alterations, such as impaired sensory processing and dysregulated homeostasis.

Mechanisms of sweating regulation

Autonomic nervous system (ANS)

Sweating is regulated by the autonomic nervous system. The primary pathway involves activation of nerve fibres that release the neurotransmitter, acetylcholine, which binds to receptors on sweat glands. This process enables temperature regulation by dissipating heat through evaporative cooling.⁷

Triggers for excessive sweating

Excessive sweating, or hyperhidrosis, occurs when sweating exceeds physiological requirements. It can be classified as:⁸

• Primary hyperhidrosis: Idiopathic and localised to specific regions, often triggered by emotional or thermal stimuli
• Secondary hyperhidrosis: Caused by systemic or neurological conditions such as hormonal imbalances (e.g., hyperthyroidism), stress, diabetes, or autonomic dysfunction. Stress, in particular, activates the hypothalamic-pituitary-adrenal (HPA) axis, causing excessive sweating

Potential connections between migraines and sweating

Shared pathophysiology

Migraines and excessive sweating share potential involvement of the autonomic nervous system. In migraines, ANS dysfunction has been implicated, including abnormal sympathetic hyperactivity or parasympathetic hypoactivity. These disruptions may contribute to the vascular and sensory symptoms of migraine and could simultaneously dysregulate sweating mechanisms.^9,10

The hypothalamus, which regulates both the ANS and thermoregulation, plays a central role in migraine pathophysiology. Hypothalamic dysfunction observed in neuroimaging studies of migraineurs could link migraines to profuse sweating. Additionally, migraines involve altered levels of neurotransmitters like serotonin and norepinephrine, which are known to influence autonomic functions, including sweat gland activity.^1,2

Sweating as a symptom during migraines

Excessive sweating is sometimes reported during the prodrome or headache phases of a migraine. Prodrome symptoms, governed by hypothalamic activity, may include autonomic signs like yawning, fatigue, and sweating. During the headache phase, sweating might occur as part of a broader autonomic activation, particularly in individuals experiencing associated nausea or flushing.¹¹

Medication side effects

Migraine treatments, particularly triptans (5-HT1B/1D receptor agonists), can influence autonomic functions. These medications may inadvertently stimulate sweating through serotonergic pathways or by interacting with central autonomic centres. Similarly, ergotamine derivatives, another migraine treatment class, have been associated with sympathetic side effects, including increased sweating.¹²

Clinical observations and studies

Case reports

Case reports have documented instances where profuse sweating coincides with migraine episodes, particularly in the prodrome and headache phases. These cases highlight the role of autonomic dysfunction, with excessive sweating possibly acting as an associated symptom rather than a standalone disorder.¹³ Sweating during migraines is often reported in conjunction with other autonomic symptoms such as flushing and nasal congestion, reinforcing the hypothesis of ANS involvement.²

Epidemiological data

Studies examining the prevalence of sweating symptoms in migraine sufferers suggest that autonomic symptoms, including diaphoresis, occur in up to 25% of patients during migraine attacks. These findings point to the role of ANS dysfunction in migraines, with a subset of patients experiencing hyperhidrosis as a defining symptom.¹⁴

Experimental studies

Experimental research has focused on autonomic function tests in migraineurs. Abnormalities, such as altered heart rate variability and sweat output during sympathetic stimuli, suggest impaired ANS regulation. Functional neuroimaging studies also demonstrate hypothalamic hyperactivity during migraines, which may explain excessive sweating as part of a broader dysregulation of autonomic and endocrine systems.¹⁴

Differential diagnoses

Hyperhidrosis as a standalone condition

Primary hyperhidrosis typically presents without other neurological symptoms and is localised to specific regions like palms, axillae, and soles. Differentiating primary hyperhidrosis from secondary causes like migraines requires evaluating symptom timing and systemic involvement.¹²

Hormonal disorders

Conditions such as hyperthyroidism can cause generalised sweating and should be excluded through thyroid function tests. Hormonal fluctuations, particularly in women, can exacerbate both sweating and migraines, necessitating a comprehensive hormonal profile.¹²

Anxiety disorders

Anxiety disorders frequently co-occur with migraines and are linked to excessive sweating due to HPA axis overactivation. Identifying anxiety as a primary or contributing factor is crucial for effective management.¹²

Implications for diagnosis and management

Diagnostic approach

A detailed history is essential to correlate sweating episodes with migraine phases. Diagnostic tools like the Migraine Disability Assessment (MIDAS) questionnaire and autonomic function tests can aid in identifying ANS involvement.

Management strategies

Some strategies to manage the condition include:¹⁵ 

• Addressing ANS dysfunction: Beta-blockers and biofeedback techniques can stabilise autonomic imbalances
• Medication adjustments: Reviewing migraine treatments (e.g., triptans or ergotamines) that may exacerbate sweating
• Lifestyle modifications: Stress management techniques, hydration, and avoiding known triggers for both migraines and sweating

Summary 

Migraines and excessive sweating are increasingly recognised as potentially interconnected conditions, sharing a common neurological basis rooted in dysfunction of the autonomic nervous system (ANS) and hypothalamic dysregulation. The ANS, which controls involuntary functions like sweating and vascular regulation, is often disrupted in migraines, leading to symptoms such as flushing, nasal congestion, and, in some cases, excessive sweating. 

The hypothalamus, a critical brain region involved in both thermoregulation and migraine pathophysiology, further underscores this link, as its dysregulation may simultaneously trigger migraine symptoms and sweating episodes. Recognising this connection is crucial for improving diagnostic precision, allowing clinicians to identify overlapping symptoms that might otherwise be attributed to unrelated conditions. 

Comprehensive patient care necessitates a multidisciplinary approach involving neurologists, endocrinologists, and dermatologists, each contributing expertise to address the complex interplay between migraines and sweating. Moreover, there is a pressing need for further research to elucidate the underlying mechanisms, particularly the role of neurotransmitters and central autonomic pathways, which could lead to innovative, targeted therapies that address both conditions simultaneously. Such advancements would improve patient outcomes and enhance the quality of life for those affected by these often debilitating symptoms.